Sutro Biopharma Company

Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.
Technology: Biologics
Industry: Women Cancer Treatment
Headquarters: South San Francisco, California, United States
Founded Date: 2003
Employees Number: 51-100
Funding Status: IPO
Total Funding: $347 000 000
Estimated Revenue: $10M to $50M
Last Funding Date: 2020-12-14
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership